Polyvalent anti-dengue vaccine

Details Polyvalent anti-dengue vaccine Polyvalent anti-dengue vaccine

C - Chemistry, Metallurgy

12

N

C12N 15/40 (2006.01) A61K 31/70 (2006.01) A61K 39/12 (2006.01) A61K 39/29 (2006.01) A61K 39/295 (2006.01) A61K 48/00 (2006.01) C07K 14/18 (2006.01) C12N 15/51 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2235334

Polyvalent subunit vaccine against the Flaviviridiae particularly against the Dengue virus, comprising recombinant peptides issued from each serotype, of which the carboxylated extremity is substituted by a peptide containing from 2 to 8 histidines, tryptophanes or cysteines.

Vaccin sous-unités polyvalent contre des Flaviviridiae notamment contre le virus de la Dengue, comprenant des peptides recombinants issus de chaque sérotype, dont l'extrémité carboxylée est substituée par un peptide contenant 2 à 8 histidines, tryptophanes ou cystéines.

Affiliated with

Also associated with

Rating

Polyvalent anti-dengue vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polyvalent anti-dengue vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyvalent anti-dengue vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1726446